LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

Search

Laboratory Corp of America Holdings

Slēgts

SektorsVeselības aprūpe

255.92 -1.23

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

254.31

Max

256.1

Galvenie mērījumi

By Trading Economics

Ienākumi

113M

278M

Pārdošana

22M

3.5B

P/E

Sektora vidējais

23.563

49.712

EPS

4.25

Dividenžu ienesīgums

1.09

Peļņas marža

7.858

Darbinieki

71,000

EBITDA

130M

548M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+19.38% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

1.09%

2.36%

Nākamie ieņēmumi

2026. g. 23. jūl.

Nākamais dividenžu datums

2026. g. 10. sept.

Nākamais Ex dividenžu datums

2026. g. 27. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

108M

22B

Iepriekšējā atvēršanas cena

257.15

Iepriekšējā slēgšanas cena

255.92

Ziņu noskaņojums

By Acuity

50%

50%

140 / 342 Rangs Healthcare

Laboratory Corp of America Holdings Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Par Laboratory Corp of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
help-icon Live chat